GFN•TV will bring the conference's platform for rational and inclusive debate on the future role of safer nicotine products and tobacco harm reduction to an audience all year round. GFN•TV will also be broadcasting live from Warsaw in June. Tune in to hear world-leading experts, tobacco harm reduction advocates and nicotine consumers discuss the latest scientific, regulatory and policy developments. From our unique annual event, to year-round reporting of the issues that matter in tobacco harm reduction, GFN has got it covered.
Less Ideology, More Science | GFN Wishes for 2026 with Fiona Patten and Fernando Bueno
As 2026 approaches, policymakers face a critical choice: continue repeating failed tobacco strategies or finally listen to science, consumers, and real-world evidence. In this discussion, Fiona Patten and Fernando Bueno examine why Australia’s tobacco tax revenue has collapsed, how harm reduction products like vaping are being wrongly regulated, and what countries like Sweden and New Zealand have done differently to dramatically cut smoking rates. The message is clear: less ideology, more evidence and a smarter, risk-based approach to public health.
📅 15 Dec 2025
#GFN25 Science Discussion #8 | The Next Frontier in Advancing THR: Oral Nicotine Products
In another Science lab presentation, Dr Chris Junker (BAT) shows the latest scientific findings on oral nicotine pouches and discusses how nicotine pouches can advance tobacco harm reduction.
📅 12 Dec 2025
GFN News #168 | INSIDE TOBACCO HARM REDUCTION IN 2025
Join us for a fast-moving roundup of the most significant tobacco harm reduction developments of 2025. From FCTC COP11 controversies and global bans to new scientific insights, advocacy efforts, and major policy shifts, Will Godfrey breaks down the year’s biggest stories. Discover where progress is being made, where setbacks continue, and how real-world consumers are shaping the future of safer nicotine.
📅 10 Dec 2025
GFN News #167 | WHY MORE COUNTRIES ARE FIGHTING FOR TOBACCO HARM REDUCTION?
Join GFN.TV and Michael Landl from the World Vapers Alliance as they break down COP11’s impact on tobacco harm reduction. Discover how countries challenged WHO recommendations, delayed restrictive measures, and pushed for evidence-based policies. Learn what this means for EU regulations, harm reduction strategies, and the global fight for safer nicotine alternatives.
📅 8 Dec 2025
GFN News #166 | WHAT HAPPENED AROUND FCTC's COP11?
Join Joanna Junak on GFN News as she speaks with Kurt Yeo, co-founder of Vaping Saved My Life, about the key moments and conversations surrounding COP11. Kurt shares his impressions from the unofficial Good COP 2.0 meeting in Geneva and offers insights into the broader discussions on harm reduction and tobacco policy.
📅 3 Dec 2025
#GFN25 Science Discussion #7 | Driving Trust in Nicotine Product Safety Through Smart Site Selection and Innovative Trial Design
Next in our Science Lab sessions, Chloe Rose PhD presents on the importance of properly designed studies and trials to determine the safety and relative risk of nicotine products.
📅 1 Dec 2025
GFN News #165 | WHY NEW ZEALAND WAS SHAMED FOR REDUCING SMOKING?
In this exclusive GFN News interview, Joanna Junak speaks with Nancy Loucas, CAPHRA Executive Coordinator, about the fallout from COP11 in Geneva and the controversial Dirty Ashtray Award given to New Zealand.
📅 28 Nov 2025
#GFN25 Science Discussion #6 | Misunderstanding nicotine delivery: a discussion on nicotine pouches
Misunderstanding nicotine delivery: a discussion on nicotine pouches. PMI's Carrie Wade and Gizelle Baker discuss the problems with comparing nicotine content of pouches with combustible tobacco. #GFN25 Science Lab discussions
📅 26 Nov 2025
GFN Voices 2025 #18 | How Moral Panic Is Killing Harm Reduction?
This GFN Voices 2025 episode brings together advocates, scientists and campaigners from around the world to share why the Global Forum on Nicotine matters, how tobacco harm reduction is being misunderstood, and why honest communication, access to safer products and open debate are essential for helping people move away from smoking.
📅 24 Nov 2025
#GFN25 Science Discussion #5 | Association Between HTP Use and Incidence of Respiratory Symptoms
In this episode of Science Lab, we break down new clinical evidence on how Heated Tobacco Products (HTPs) compare to traditional cigarettes in terms of respiratory health. Using biomarker data, symptom tracking, and real-world study outcomes, she explains what happens when smokers switch completely to HTPs — and how this transition may influence the incidence and severity of respiratory symptoms.
